Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? - Wikidata - wikimedia - TriplyDB

Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?

Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?

http://www.wikidata.org/entity/Q35010044

about

Antimicrobial Peptides in Human Sepsis On the role of NMR spectroscopy for characterization of antimicrobial peptides Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation The Frog Skin-Derived Antimicrobial Peptide Esculentin-1a(1-21)NH2 Promotes the Migration of Human HaCaT Keratinocytes in an EGF Receptor-Dependent Manner: A Novel Promoter of Human Skin Wound Healing?Suppression of soft tissue sarcoma growth by a host defense-like lytic peptide.Identification of a novel lytic peptide for the treatment of solid tumours.Host defense peptides for treatment of colorectal carcinoma - a comparative in vitro and in vivo analysis.Screening of antimicrobials from Caribbean sea animals and isolation of bactericidal proteins from the littoral mollusk Cenchritis muricatus.Procalcitonin neutralizes bacterial LPS and reduces LPS-induced cytokine release in human peripheral blood mononuclear cells.Innate defense regulator peptide 1018 in wound healing and wound infection Protecting the boundary: the sentinel role of host defense peptides in the skin.Antimicrobial and immunomodulatory activities of PR-39 derived peptides Immune activation efficacy of indolicidin is enhanced upon conjugation with carbon nanotubes and gold nanoparticles Pro-moieties of antimicrobial peptide prodrugs.Oncolytic activities of host defense peptides.Nylon-3 polymers with selective antifungal activity Efficacy of Lantibiotic Treatment of Staphylococcus aureus-Induced Skin Infections, Monitored by In Vivo Bioluminescent Imaging.Current developments in the therapy of protozoan infections.Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs.Antimicrobial peptides and their potential application in inflammation and sepsis Revisiting eukaryotic anti-infective biotherapeutics.The post-antibiotic era: promising developments in the therapy of infectious diseases.Structure-activity relationships among antifungal nylon-3 polymers: identification of materials active against drug-resistant strains of Candida albicans.Efficacy of the designer antimicrobial peptide SHAP1 in wound healing and wound infection.The equine antimicrobial peptide eCATH1 is effective against the facultative intracellular pathogen Rhodococcus equi in mice Genotoxic and cytotoxic activity of host defense peptides against human soft tissue sarcoma in an in vitro model.Long-term anti-endotoxin/E. coli efficacy in mice transfected with AAV2/1-muBPI25 -muFcγ1.An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule.Potential of host defense peptide prodrugs as neutrophil elastase-dependent anti-infective agents for cystic fibrosis.The thin line between cell-penetrating and antimicrobial peptides: the case of Pep-1 and Pep-1-K.The Immunomodulatory Drug Glatiramer Acetate is Also an Effective Antimicrobial Agent that Kills Gram-negative Bacteria.Antimicrobial Activity of NCR Plant Peptides Strongly Depends on the Test Assays

P2860

Q26782811-9B7BDDBC-10EA-412E-AB6C-0B0E37BB82B2 Q26830116-38ED0714-7B28-4298-95BB-A540AB3E7A89 Q28534617-E2FCC467-AF7E-4848-B264-90ED93BBAC02 Q28548287-5E7A9CA5-A157-44D6-8A9E-687FD2A6B18D Q33869797-8FE2DC76-6D49-4A17-8513-18F631476897 Q33925341-5F685A94-A1A9-469B-B462-689A80FED948 Q34101011-97F946D9-7A4E-4C21-9A0E-4CD4A4260E3C Q34172764-50B40EED-31A8-4071-891B-9DBBCAE1B4EE Q34262422-229AAD6E-86BB-466D-85CA-98E5B0A77A77 Q34373912-D86FE699-F33D-42EF-8614-64BF9EBBEF56 Q35075143-D66E2CE7-09D5-4288-A024-951616E0B357 Q35154887-5322723F-9786-4148-BFCD-AFA00E71048D Q35433503-6D5757A4-F8FA-4A0D-ACF7-314B8BBBB813 Q35543287-C74FE4BA-B221-4166-97E2-7021D5FAA33A Q35600198-630AAC8C-0DF5-4825-A118-E247196A3796 Q36933390-93C6FAE3-5A8C-431C-AB5C-8C2F98FD7A94 Q37023281-ABAEE19C-DBE1-4816-A70E-657FBDE20DC3 Q37883063-D0B3B36A-6954-4F34-88BC-2804D2BB7A81 Q37909413-D6AD0D1C-47D8-4059-BD43-617574339288 Q37994886-D8D9C50F-F5A4-4389-95F3-DD50FA6F49DF Q38073892-CD2E6F31-ED4C-4017-AAD0-F5A5082CF58F Q38106970-6FA352CB-357F-46B2-AC0F-309ABA90CC0C Q38740925-247C1705-A374-45DE-9A49-CB833D385B40 Q38982372-E2556626-E42D-48C6-B250-5D29E5324A9F Q39132044-EF5A482D-B7E5-442B-B5A6-5F52C4F01F51 Q39488599-CA20D6EC-48AF-4BA7-9E55-5DA22238A01D Q39512821-B734BE7A-AE2D-4476-9B8E-C18E24D5ECB1 Q41033958-36967261-111B-4468-B6D0-19A89F2C98B4 Q41907587-B68C546B-1878-4F42-AD7C-4649D4453A8D Q46850580-D721D2E8-AA3F-414D-B58A-D559C517C2BA Q47102307-C3732D2C-A896-4AF0-A6A5-986234FFBD25 Q58693719-8E0CA338-A88B-4F66-810B-15E3DA458D84

P2860

Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?

http://www.wikidata.org/entity/Q35010044

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Host defense peptides as effec ...... dgehammer for drug resistance?

@ast

Host defense peptides as effec ...... dgehammer for drug resistance?

@en

type

label

Host defense peptides as effec ...... dgehammer for drug resistance?

@ast

Host defense peptides as effec ...... dgehammer for drug resistance?

@en

prefLabel

Host defense peptides as effec ...... dgehammer for drug resistance?

@ast

Host defense peptides as effec ...... dgehammer for drug resistance?

@en

P1433

Q35010044-BA687CF0-55C7-485D-80F6-329F5A9D6D5B

P1476

Q35010044-E59571DA-9FF6-4390-8D88-D423E9D48CA4

P2093

Q35010044-24632D3B-45F2-4ADB-8077-45DAE9BB620D

Q35010044-4CC96468-BC3C-4113-B2B9-3C930F2B4C4E

Q35010044-6D421741-A063-424E-B94D-C96EC9D1E042

Q35010044-6E6F2C02-DA80-4737-B438-DFBE0F1C6D85

Q35010044-BD372896-4615-4C66-B9B2-3BF60A1D841A

Q35010044-E05F275D-EAB8-42DB-8896-E4CA75081F4A

P275

Q35010044-6B9FC474-13F2-4092-B309-70DE5ED7D712

P2860

Q35010044-017E089F-D643-44D2-838F-394590EEA3A1

Q35010044-0194D3F6-A1C3-40F1-AFAF-4A1A14FE2602

Q35010044-0496D506-08FB-4D9C-867F-82296EE7F865

Q35010044-04C569D7-D87F-40F6-B5B7-E3FE83F01A5D

Q35010044-05C3B572-788E-41CA-ABC1-BC144273C7F0

Q35010044-0E29E4EC-8F8F-41A5-88B5-98BCDF05381B

Q35010044-10791398-926E-4BA6-91A0-E075E652FCE8

Q35010044-14C1A2F0-D1B6-4611-8ED3-2ED26F399402

Q35010044-1562FCC3-E7D9-47DB-A8B9-5B82C700A0C2

Q35010044-1860AB04-21C9-4EC2-9328-494BE9FC70C0

P304

Q35010044-A8F3A6CA-F153-49F2-8BB3-4FBE2AD693C4

P31

Q35010044-674659D6-DCA1-451E-98D4-2E4E45B9F37E

P356

Q35010044-81F11939-EA72-4413-B6D6-F223108D8092

P407

Q35010044-30D61C8A-AFE8-4136-984D-A94DBFED4E36

P433

Q35010044-851E48FF-0B53-45D9-82AC-135C911ED4E4

P478

Q35010044-712FBE4C-8B33-482D-B6A3-62F9C2B3F70C

P50

Q35010044-F64B64BD-1838-45A9-899B-12A4AF5BD667

P577

Q35010044-E50E2D29-5B8F-40B2-AE17-B77D2BDE6627

P5875

Q35010044-EC70B019-225D-48B2-A5B2-9B19D8A7D194

P698

Q35010044-C3431AA3-2A3C-4196-946F-854BD5A7E075

P921

Q35010044-00CA266F-139D-4E8B-8A3E-4F8A765386F6

Q35010044-E1FDE307-B221-425C-BFDB-8374E152A70D

Q35010044-EDBABB3C-AA9E-4CC7-89BE-CF759F4C15DE

P932

Q35010044-DA368755-78AB-43EC-94F6-0C8D79BD5FE4

P356

P1433

International Journal of Molecular Sciences

P1476

Host defense peptides as effec ...... dgehammer for drug resistance?

@en

P2093

Frank Jacobsen

http://www.w3.org/2001/XMLSchema#string

Hans-Ulrich Steinau

http://www.w3.org/2001/XMLSchema#string

Lars Steinstraesser

http://www.w3.org/2001/XMLSchema#string

Marco Kesting

http://www.w3.org/2001/XMLSchema#string

Tobias Hirsch

http://www.w3.org/2001/XMLSchema#string

Ursula M Kraneburg

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6

PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancer

Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity

Antibiotic proteins of human polymorphonuclear leukocytes

Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3

Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein

Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides

Antimicrobial peptides of multicellular organisms

Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group

Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells

P304

3951-3970

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS10093951

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38044554

http://www.w3.org/2001/XMLSchema#string

P698

19865528

http://www.w3.org/2001/XMLSchema#string

P921

membrane proteins

physiological phenomena

P932

2769137

http://www.w3.org/2001/XMLSchema#string